All IMO
Nupapa
Recent RIGL News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 10:18:08 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:33:13 PM
- Rigel to Present at the Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:22:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:40 PM
- Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 11/07/2024 09:01:00 PM
- Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition • PR Newswire (US) • 11/05/2024 02:05:00 PM
- Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update • PR Newswire (US) • 10/31/2024 12:05:00 PM
- Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) • PR Newswire (US) • 10/24/2024 08:35:00 PM
- Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE® • GlobeNewswire Inc. • 10/16/2024 02:00:00 PM
- Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 10/04/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 08:01:11 PM
- Rigel to Present at the 2024 Cantor Global Healthcare Conference • PR Newswire (US) • 09/12/2024 12:05:00 PM
- Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML • PR Newswire (US) • 09/05/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:36:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 12:33:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:30:20 PM
- Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan • PR Newswire (US) • 09/03/2024 12:00:00 PM
- Rigel to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/29/2024 12:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/12/2024 04:15:12 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 09:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:11:12 PM
- Rigel Reports Second Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 08/06/2024 08:01:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/02/2024 08:53:03 PM
- Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update • PR Newswire (US) • 07/30/2024 12:05:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM